Massive bladder hemorrhage after cystoscopy in a patient with secondary systemic amyloidosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4684548)

Published in J Urol on January 01, 1973

Authors

J E Montie, B H Stewart

Articles by these authors

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol (2000) 4.28

Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 3.92

Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology (2001) 2.34

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med (1991) 2.07

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J Urol (1999) 2.03

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. Urology (1999) 1.92

Bladder tumor detection at virtual cystoscopy. Radiology (2001) 1.74

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol (2000) 1.70

Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med (1979) 1.49

Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33

Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29

Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol (1989) 1.26

Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. J Urol (2000) 1.22

Experience with extra-adrenal pheochromocytoma. J Urol (1989) 1.20

Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Pharm Res (2000) 1.19

Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol (2000) 1.18

Acquired rectourethral fistula: methods of repair. J Urol (1995) 1.17

The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness. J Urol (2001) 1.16

Nephron sparing surgery for suspected malignancy: open surgery compared to laparoscopy with selective use of hand assistance. J Urol (2000) 1.14

Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg (1990) 1.13

Mortality and morbidity in pretransplant bilateral nephrectomy: analysis of 305 cases. Urology (1978) 1.13

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion. J Clin Pharmacol (2000) 1.12

The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol (1977) 1.11

Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology (1995) 1.10

Localization of pheochromocytoma by computed tomography. N Engl J Med (1978) 1.09

Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J Biol Chem (1992) 1.07

Four years' clinical experience with 138 kidney transplants. J Urol (1968) 1.06

Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment. J Urol (2001) 1.06

Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59. Blood (1990) 1.05

Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study. Prostate (1997) 1.03

Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders. Urology (1978) 1.01

The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol (1989) 1.00

Left renal venous hypertension "nutcracker" syndrome. Managed by direct renocaval reimplantation. Urology (1982) 1.00

Comparison of patients' and physicians' rating of urinary incontinence following radical prostatectomy. Semin Urol Oncol (2000) 0.99

Clinical and in vitro magnetic resonance imaging of prostatic carcinoma. AJR Am J Roentgenol (1984) 0.98

Staging of prostate cancer. Cancer (1994) 0.97

Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens. J Natl Cancer Inst (2000) 0.96

Bilateral emphysematous pyelonephritis. Urology (1985) 0.96

Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? J Urol (2001) 0.95

Retroperitoneal neural sheath tumors: Cleveland Clinic experience. J Urol (1989) 0.94

Diminished operative morbidity and mortality in renal revascularization. JAMA (1981) 0.93

Surgery for renal cell carcinoma extending into the inferior vena cava. J Urol (1978) 0.91

Retroperitoneal malignancy masquerading as benign retroperitoneal fibrosis. J Urol (1970) 0.91

Selective screening device for the early detection of normal or delayed cognitive development in infants at risk for later mental retardation. Pediatrics (1986) 0.90

Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women. J Urol (2000) 0.90

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology (2000) 0.90

Combination radiation and chemotherapy for the treatment of squamous cell carcinoma of the male and female urethra. J Urol (1995) 0.90

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. J Pharm Sci (1999) 0.90

Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol (1984) 0.90

Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. J Urol (1970) 0.89

Splenorenal bypass in the treatment of stenosis of the renal artery. Surg Gynecol Obstet (1977) 0.89

Surgical treatment of renal artery aneurysms. Br J Urol (1983) 0.88

Renal revascularization in patients with total occlusion of the renal artery. J Urol (1980) 0.88

Lymphocytes associated with renal transplantation. Report of 15 cases and review of the literature. Am J Med (1974) 0.87

Stomal complications of intestinal conduit urinary diversion. Cleve Clin J Med (1989) 0.87

Intra-arterial chemotherapy as an adjuvant to surgery in transitional cell carcinoma of the bladder. J Urol (1986) 0.87

Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol (1989) 0.87

Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J Pharm Sci (1996) 0.87

Anesthetic management for surgical removal of renal carcinoma with caval or atrial tumor thrombus using deep hypothermic circulatory arrest. J Cardiothorac Anesth (1989) 0.87

Retransplantation after failure of first renal homografts. Studies in 19 patients. JAMA (1967) 0.86

Varicocele in infertility: incidence and results of surgical therapy. J Urol (1974) 0.86

Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder. J Urol (1976) 0.86

Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties. J Med Chem (1997) 0.86

Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst (1995) 0.86

Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scand J Urol Nephrol Suppl (2000) 0.86

Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. J Urol (1990) 0.86

The psychosocial aspects of sexual recovery after prostate cancer treatment. Int J Impot Res (2009) 0.86

Lymphadenectomy in renal adenocarcinoma. J Urol (1982) 0.86

Adrenal surgery--current state of the art. J Urol (1983) 0.85

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer. Urology (2000) 0.85

Prospective comparison between hand-assisted laparoscopic and open surgical nephroureterectomy for urothelial cell carcinoma. Urology (2001) 0.85

Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds. Pharm Res (1998) 0.85

Four years' clinical experience with 138 kidney transplants. Trans Am Assoc Genitourin Surg (1967) 0.85

The use of ninety-four cadaveric kidneys for transplantation--clinical experience. Br J Urol (1966) 0.84

Surgical management of branch renal artery disease: in situ versus extracorporeal methods of repair. J Urol (1980) 0.84

Revascularization of the kidney after occlusion of the aorta and both renal arteries. Surgery (1976) 0.84

Cutaneous ureterostomy as palliative diversion in adults with malignancy. Urology (1987) 0.83

Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer. J Ultrasound Med (2001) 0.83

Radical cystectomy for carcinoma of the bladder in the elderly patient. J Urol (1987) 0.83

Free flap phalloplasty. J Urol (1982) 0.83

Pulmonary embolus presenting as the initial manifestation of renal cell carcinoma. Ann Thorac Surg (1977) 0.83

Extracorporeal renal surgery and autotransplantation: indications, techniques and results. J Urol (1980) 0.83

Differential renal venous renin activity in diagnosis of renovascular hypertension. Review of 29 cases. Am J Cardiol (1973) 0.82

Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994. Cancer (1996) 0.82

Testicular cancer: diagnosis and staging. Semin Urol (1984) 0.82

Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis. J Urol (1976) 0.82

Partial nephrectomy in the treatment of renal adenocarcinoma. J Urol (1977) 0.82

CT-guided antegrade pyelography and percutaneous nephrostomy. AJR Am J Roentgenol (1977) 0.82

Surgical treatment of retroperitoneal fibrosis. Ann Surg (1969) 0.81

Renal revascularization in patients with severe atherosclerosis of the abdominal aorta or a previous operation on the abdominal aorta. Surg Gynecol Obstet (1977) 0.81

Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venacavography and computerized tomography scanning. J Urol (1990) 0.81

A new simplified approach to the diagnosis of pheochromocytoma. J Urol (1979) 0.81

Male infertility: an optimistic report. J Urol (1973) 0.81

Preoperative blood transfusion in the safe surgical management of pheochromocytoma: a review of 46 cases. J Urol (1974) 0.81

Mechanisms of incontinence and retention after orthotopic neobladder diversion. Urology (1998) 0.81

Management of the urethra in men undergoing radical cystectomy for bladder cancer. J Urol (1984) 0.80

Long-term results following partial nephrectomy for localized renal adenocarcinoma. J Urol (1984) 0.80